Synthesised thymoquinone-oxime induces cytotoxicity, genotoxicity and apoptosis in hepatocellular cancer cells: in vitro study

References

• Ahmed WA, Hassan SA, Galeb FM, Taweel MAE, Abu-Bedair FA. 2008. The in vitro promising therapeutic activity of thymoquinone on hepatocellular carcinoma (HepG2) cell line. Global Veterinaria. 2:233–241.
   Google Scholar
• Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. 2019. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 16(7):411–428.
   PubMed Web of Science ®Google Scholar
• Attoub S, Sperandio O, Raza H, Arafat K, Al-Salam S, Sultan MA, Safi MA, Takahashi T, Adem A. 2013. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam Clin Pharmacol. 27(5):557–569.
   PubMed Web of Science ®Google Scholar
• Awad ASM, Haleem ENAA, El-Bakly WM, Sherief MA. 2016. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 389(4):381–391.
   PubMed Web of Science ®Google Scholar
• Canario C, Silvestre S, Falcao A, Alves G. 2018. Steroidal oximes: useful compounds with antitumor activities. Curr Med Chem. 25(6):660–686.
   PubMed Web of Science ®Google Scholar
• Cancer Facts & Figures. 2021. NIH National Cancer Institute
   Google Scholar
• Chen Y-F, Chen Y-T, Chiu W-T, Shen M-R. 2013. Remodeling of calcium signaling in tumor progression. J Biomed Sci. 20(1):23.
   PubMedGoogle Scholar
• Cui C, Merritt R, Fu L, Pan Z. 2017. Targeting calcium signaling in cancer therapy. Acta Pharm Sin B. 7(1):3–17.
   PubMed Web of Science ®Google Scholar
• Das S, Bera D, Pal K, Mondal D, Karmakar P, Das S, Dey A. 2020. Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: an in vitro study on bacterial and hepatocellular carcinoma cells. J Drug Deliv Sci Technol. 60:101994.
   Web of Science ®Google Scholar
• Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H. 2017. The anti-tumor activities of neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via snail signaling in hepatocellular carcinoma. Sci Rep. 7:41616.
   PubMed Web of Science ®Google Scholar
• Jehan S, Zhong C, Li G, Bakhtiar SZ, Li D, Sui G. 2020. Thymoquinone selectively induces hepatocellular carcinoma cell apoptosis in synergism with clinical therapeutics and dependence of p53 status. Front Pharmacol. 11:555283.
   PubMed Web of Science ®Google Scholar
• Kale E, Kale A, Bozali K, Gulgec AS, Ozdemir M, Yalcin B, Guler EM. 2022. T Q-Ox, a novel synthetic derivative of thymoquinone on ovarian cancer cells in vitro. Nat Prod Res. 2022 Nov 22:1–10. doi:10.1080/14786419.2022.2144298. Epub ahead of print. PMID: 36412544.
   PubMed Web of Science ®Google Scholar
• Khader M, Eckl PM. 2014. Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci. 17:950–957.
   PubMed Web of Science ®Google Scholar
• Khan A, Chen H-c, Tania M, Zhang D-z 2011. Anticancer activities of Nigella sativa (black cumin). AJOL. 8:226–232.
   Google Scholar
• Kim IH, Kim SW, Kim SH, Lee SO, Lee ST, Kim DG, Lee MJ, Park WH. 2012. Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model. Exp Mol Med. 44(7):448–456.
   PubMed Web of Science ®Google Scholar
• Kolsi LE, Leal AS, Yli-Kauhaluoma J, Liby KT, Moreira VM. 2018. Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1. Sci Rep. 8(1):15923.
   PubMedGoogle Scholar
• Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. 2021. Hepatocellular carcinoma. Nat Rev Dis Primers. 7(1):6
   PubMed Web of Science ®Google Scholar
• Mabrouk A, Salah IBH, Chaieb W, Cheikh HB. 2016. Protective effect of thymoquinone against lead-induced hepatic toxicity in rats. Environ Sci Pollut Res Int. 23(12):12206–12215.
   PubMed Web of Science ®Google Scholar
• McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Ve R. J. M Y, et. al. 1995. «The end of the (cell) line: methods for the study of apoptosis in vitro». Methods Cell Biol. 46:153–185.
   PubMed Web of Science ®Google Scholar
• Nishida N, Yada N, Hagiwara S, Sakurai T, Kitano M, Kudo M. 2016. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 31(9):1646–1653.
   PubMed Web of Science ®Google Scholar
• Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. 2007. Mitochondria, oxidative stress and cell death. Apoptosis. 12(5):913–922.
   PubMed Web of Science ®Google Scholar
• Perryman SV, Sylvester KG. 2006. Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. J Cell Mol Med. 10(2):292–308.
   PubMed Web of Science ®Google Scholar
• Qin H-L, Leng J, Zhang C-P, Jantan I, Amjad MW, Sher M, Naeem-Ul-Hassan M, Hussain MA, Bukhari SNA. 2016. Synthesis of α,β-unsaturated carbonyl-based compounds, oxime and oxime ether analogs as potential anticancer agents for overcoming cancer multidrug resistance by modulation of efflux pumps in tumor cells. J Med Chem. 59(7):3549–3561.
   PubMed Web of Science ®Google Scholar
• Rottenberg H, Wu S. 1998. Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim Biophys Acta. 1404(3):393–404.
   PubMed Web of Science ®Google Scholar
• Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA.. 2016. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 22:1312–1337.
   Google Scholar
• Samarghandian S, Azimi-Nezhad M, Farkhondeh T. 2019. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells. J Cell Physiol. 234(7):10421–10431.
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Plotnikov MB, Khlebnikov AI, Plotnikova TM, Quinn MT. 2021. Oximes: novel therapeutics with anticancer and anti-inflammatory potential. Biomolecules. 11(6):777.
   PubMed Web of Science ®Google Scholar
• Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. 2018. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 24(7):908–922.
   PubMed Web of Science ®Google Scholar
• Singh N, McCoy M, Tice R, Schneider E. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175(1):184–191.
   PubMed Web of Science ®Google Scholar
• Sintra S, Tomé L, Cipriano M, Bento C, Furtado E. 2013. Long-term outcome of the first 150 liver transplant recipients: a single-center experience. Transplant Proc. 45(3):1119–1121.
   PubMed Web of Science ®Google Scholar
• Villanueva A. 2019. Hepatocellular carcinoma. N Engl J Med. 380(15):1450–1462.
   PubMed Web of Science ®Google Scholar
• Yang C, Lim W, Bazer FW, Song G. 2017. Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress. Cancer Lett. 399:10–19.
   PubMed Web of Science ®Google Scholar